-+ 0.00%
-+ 0.00%
-+ 0.00%

HOTH THERAPEUTICS ISSUES COMPREHENSIVE PIPELINE UPDATE HIGHLIGHTING CLINICAL PROGRESS, ORPHAN-DESIGNATED HT-KIT, ADVANCING HT-001 PHASE 2, AND NEW GDNF METABOLIC PROGRAM

Reuters·12/03/2025 19:00:00

Please log in to view news